Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples